Bioelectronics Corp (BIEL)

[J-Rhino]

Do you have a link?EDIT: found it

Thursday, December 09, 2010

Recent Updates – BioElectronics Corporation

BioElectronics has many investor updates to share, in addition to the press release that went out today about our product improvements. These updates include PR activity in UK, Allay UK TV test, Allay TV appearances, FDA clarification request, HealFast at Baltimore equine show, new Canadian ActiPatch commercial, Eastern European orders, and exciting case study results.

United Kingdom Public Relations Activity: We hired the services of Premier PR, a leading PR firm in the UK, to enhance and maximize our Allay campaign. Through the use of strong PR activities, we aim to establish retail sales in the UK, and gain better awareness of the product benefits and brand messages. To learn more about Premier PR, please visit www.premierpr.com.

Allay UK Television Test: After an initial, successful two week television test in the UK, we are excited to launch phase B of our TV test. In phase B, we are using a different commercial, targeting a younger demographic. The commercial will air by the end of the year on SKY satellite channels and E4 terrestrial channel. Both venues capture a very large audience. The new airing schedule will expose our commercial to 1.2m actual viewers in our target population.

Allay Television Appearances: We were happy to see Allay on “The Doctors” show last week. This TV exposure follows many other coverage items, where we continue to strengthen our brand. Allay is also scheduled to appear in Canada on the GlobalTV channel, in upcoming weeks. To see all our past TV items, including the item from “The Doctors,” please visit http://bielcorp.com/products/allay/allay-in-the-news/.

Allay DeNovo Application with the US-FDA: Earlier this week, BioElectronics received a letter from the US-FDA asking for clarifications about our Allay DeNovo application. A DeNovo application is submitted for devices that have no predicate and are of low-risk. The application requests the FDA to create a new classification and category, thus establishing a need for category controls. The FDA requested us to further define general controls for the new category and clarify previously presented clinical information. We are formulating our response, with help from several experts in the fields of bio-physics, medicine, FDA regulations and statistics.

HealFast Equine Show Appearance: BioElectronics’ HealFast was exhibited this week at the annual convention of the American Association of Equine Practitioners in Baltimore. eMarkets Group, LLC, the distributor of HealFast, introduced our new and improved shorter duration and lower cost product device into their product line and exhibited the new device at the convention.

New ActiPatch Canadian Commercial: We have a new edit for our back pain commercial currently running in Canada. Early results of the new commercial show an increase in our sales, but we need to obtain better repetitions and overall optimization to achieve our target numbers. To view our spot, please click HERE.

Eastern Europe Orders: Our Eastern European distributor Union Bionic, has made an initial order for new countries: Czech Republic, Poland, Ukraine and Hungary. We look forward to their successful campaigns and repeat orders.

Happy Story for the End: Our distributor in Netherlands started a new test for wound care in a leading Dutch medical institution. One of the test patients is a 105 year old woman who had bad diabetic ulcer on her leg. Within a week of using RecoveryRx, the black borders of her wound disappeared, and her wound was closing very fast, while the hyper-granulation diminished. These stories are the reason we are in this business – - we want to help many more patients experience the same results and change the way people heal.

http://bielcorp.com/investors/investor-updates/